Lujun Shen - Sun Yat-Sen University Cancer Center

基本信息

浏览量：55

职业迁徙

个人简介

Lujun Shen currently works at the Sun Yat-sen University Cancer Center, Sun Yat-Sen University. Lujun does research in Computer Graphics, Clinical Big Data and Omics Analysis. Their current project is 'Enhanced immunotherapy through local modulation' and "data driven clinical decision making".

研究兴趣

论文共 130 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

PD-1 Inhibitor-Augmented HAIC-TKI Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Real-World Survival Benefits, Safety, and Subgroup-Specific Efficacy

Fei Cao, Chunyong Wen,Yujia Wang,Hongtong Tan, Shaohuan Hao,Jinbin Chen,Shuanggang Chen,Lujun Shen,Lin Xie,Han Qi,Tao Huang,Yaojun Zhang,Zilin Huang

Frontiers in Immunology (2025)

引用0浏览0引用

Comparison of the Effectiveness of Transarterial Bland Embolization and Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Propensity Score- Matched Study of 1,008 Patients

Hongmin Zhang,Jian Xu, Haoyu Meng,Lujun Shen

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGYno. 1 (2025): 41-49

引用0浏览0引用

Survival Path Model Outperforms Conventional Static Machine Learning Models in Long-Term Dynamic Prognosis Prediction for Patients with Intermediate Stage Hepatocellular Carcinoma

Lujun Shen,Tao Zhang,Jian Xu, Yiquan Jiang,Fei Cao,Qifeng Chen, Chen Li, Gulijiayina Nuerhashi,Wang Li,Peihong Wu,Weijun Fan

Bioinformatics advancesno. 1 (2025): vbaf027-vbaf027

引用0浏览0WOS引用

Hepatic Artery Infusion of FOLFOX Chemotherapy Plus Camrelizumab Combined with Sorafenib for Advanced Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer Stage C (Double-Ia-001): a Phase II Trial

Lujun Shen,Fei Cao, Ying Liu, Gulijiayina Nuerhashi,Letao Lin, Hontong Tan, Chunyong Wen, Yujia Wang,Shuanggang Chen, Hongliang Zou,Lin Xie,Weijun Fan

BMC Medicineno. 1 (2025): 1-9

引用0浏览0WOS引用

Identification of Candidates with Hepatocellular Carcinoma to Receive TACE Combined with MWA by Assessing Tumor Burden and Radiologic Features

Chao An,Lujun Shen,Qifeng Chen, Yiquan Jiang, Chen Li,He Ren,Peihong Wu, Xi Liu

Therapeutic advances in medical oncology (2025): 17588359251324052-17588359251324052

引用0浏览0WOS引用

The Value of No Evidence of Disease (NED) in Intermediate-Stage Hepatocellular Carcinoma after TACE: A Real-World Study

Lujun Shen, Yiquan Jiang, Yueqian Wu, Chen Li, Qi Zeng, Letao Lin,Yujia Wang,Shuanggang Chen,Fei Cao, Gulijiayina Nuerhashi, Sen Zhang,Zhongguo Zhou, Chao An, Zhicheng Du,Weijun Fan

Liver international official journal of the International Association for the Study of the Liverno. 5 (2025): e70101-e70101

引用0浏览0WOS引用

Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma